USPTO serial 79410002
ID SOLUTIONS ONCOLOGY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 20, 2026
- Examiner
- THOMAS, JULIE
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ID SOLUTIONS ONCOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
J. Scott Gerien
J. Scott Gerien Dickenson, Peatman & Fogarty1500 First Street, Ste. 200Napa, CA 94559United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical preparations, namely, precursors intended for in vitro genetic engineering; diagnostic reagents for in vitro use for biochemistry, clinical chemistry and microbiology; chemical preparations for scientific purposes intended for use in DNA analysis, other than for medical use; enzymes, other than for medical use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for nonmedical purposes; reagents for nucleic acid amplification other than for medical or veterinary use | ACTIVE | — |
| 005 | Diagnostic test kits comprised of medical diagnostic agents, preparations and substances for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects for medical purposes; chemical preparations intended for use in DNA analysis for medical use; reagents for use in medical genetic testing; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use | ACTIVE | — |
| 009 | Laboratory apparatus for detecting genetic sequences; quantitative polymerase chain reaction (PCR) instrument for scientific use, namely, thermal cycler; laboratory apparatus and automatic machines for purifying nucleic acids, not for medical purposes | ACTIVE | — |
| 010 | DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use; medical apparatus and automatic machines for purifying nucleic acids for medical use | ACTIVE | — |
| 042 | Research with respect to DNA sequencing technology; research in the field of DNA analysis technology; scientific research in the field of genetics and genetic engineering; structural and functional analysis of genomes; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of health; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of biology; software as a service (SaaS) featuring software for the design of probes and primers for quantitative polymerase chain reaction (PCR) and interpretation of quantitative polymerase chain reaction (PCR) results in the field of in vitro diagnostics; design, development and maintenance of software in the field of health; design, development and maintenance of software in the field of biology; design, development and maintenance of software in the field of in vitro diagnostics * ; all before-mentioned services only relating to applications in in vitro diagnostics of diseases and monitoring diseases * | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ID SOLUTIONS
- Other trademarks owned by ID SOLUTIONS ONCOLOGY
- Other trademarks owned by ID SOLUTIONS ONCOLOGY
- Other trademarks owned by ID SOLUTIONS ONCOLOGY
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ID SOLUTIONS ONCOLOGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 10, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 25, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Aug 6, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 5, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 5, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 5, 2026 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Aug 5, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Aug 5, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 16, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 4, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 7, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 20, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 20, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 20, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 20, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 11, 2025 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 25, 2025 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 7, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 22, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 22, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 27, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 26, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 5, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 5, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 21, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |